India Approves Its First Dengue Vaccine QDENGA For People Aged 4 to 60 Years
India has achieved a historic milestone in public health today, with the Drug Controller General of India (DCGI) officially granting market authorization for the country’s first dengue vaccine, QDENGA. Developed by Takeda Biopharmaceuticals, the live-attenuated tetravalent vaccine is approved for individuals aged 4 to 60 years and is designed to provide robust protection against all […]
Read More Text.